Movement Disorders (revue) - Exploration (Accueil)

Index « Keywords » - entrée « Drug Resistance »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Prescriptions (statistics & numerical data) < Drug Resistance < Drug Resistance (immunology)  Facettes :

List of bibliographic references indexed by Drug Resistance

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
002003 (2009) Han-Joon Kim [Corée du Sud] ; Sun Ha Paek [Corée du Sud] ; Ji-Young Kim [Corée du Sud] ; Jee-Young Lee [Corée du Sud] ; Yong Hoon Lim [Corée du Sud] ; Dong Gyu Kim [Corée du Sud] ; Beom S. Jeon [Corée du Sud]Two‐year follow‐up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease
002561 (2008) Uwe Walter [Allemagne] ; Dirk Dressler [Allemagne] ; Christian Lindemann [Chili] ; Andrea Slachevsky [Chili] ; Marcelo Miranda [Chili]Transcranial sonography findings in welding‐related Parkinsonism in comparison to Parkinson's disease
002E29 (2007) Eng-King Tan [Singapour] ; Justina Tong [Singapour] ; Ratnagopal Pavanni [Singapour] ; Meng-Cheong Wong [Singapour] ; Yi Zhao [Singapour]Genetic analysis of SCA 2 and 3 repeat expansions in essential tremor and atypical Parkinsonism
003196 (2006) Carla Cordivari [Royaume-Uni] ; Vijay Peter Misra [Royaume-Uni] ; Angela Vincent [Royaume-Uni] ; Santiago Catania [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Andrew John Lees [Royaume-Uni]Secondary nonresponsiveness to botulinum toxin A in cervical dystonia: The role of electromyogram‐guided injections, botulinum toxin A antibody assay, and the extensor digitorum brevis test
003441 (2006) Angela Deutschl Nder [Allemagne] ; Friedrich Asmus [Allemagne] ; Elena Marelli [Allemagne] ; Thomas Klopstock [Allemagne] ; Thomas Gasser [Allemagne] ; Kai Bötzel [Allemagne]Excellent response to apomorphine in Parkinsonism with optic atrophy unresponsive to oral antiparkinsonian medication
003556 (2006) Nina Browner [États-Unis] ; Shaheda N. Azher [États-Unis] ; Joseph Jankovic [États-Unis]Botulinum toxin treatment of facial myoclonus in suspected Rasmussen encephalitis
003858 (2005) Brian Berman [États-Unis] ; Lauren Seeberger [États-Unis] ; Rajeev Kumar [États-Unis]Long‐term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia
003C93 (2004) Helio A. G. Teive [Brésil] ; Renato P. Munhoz [Brésil]Hypothyroidism and Parkinson's disease
004254 (2002) Annie Lannuzel [France] ; Patrick P. Michel [France] ; Dominique Caparros-Lefebvre [France] ; Jacqueline Abaul ; Reynald Hocquemiller ; Merle Ruberg [France]Toxicity of Annonaceae for dopaminergic neurons: Potential role in atypical parkinsonism in Guadeloupe
004298 (2002) Charles H. Adler [États-Unis] ; Stewart A. Factor [États-Unis] ; Mitchell Brin [États-Unis] ; Kapil D. Sethi [États-Unis]Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia
004397 (2002) G-Y. R. Hsiung [Canada] ; S. K. Das [Canada] ; R. Ranawaya [Canada] ; A. Lafontaine [Canada] ; O. Suchowersky [Canada]Long‐term efficacy of botulinum toxin A in treatment of various movement disorders over a 10‐year period
004B19 (2000) D. Dressler [Royaume-Uni] ; G. Dirnberger [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; A. Irmer [Allemagne] ; N. P. Quinn [Royaume-Uni] ; H. Bigalke [Allemagne] ; C. D. Marsden [Royaume-Uni]Botulinum toxin antibody testing: Comparison between the mouse protection assay and the mouse lethality assay
005263 (1997) Dressler [Allemagne] ; Remt-Otto Oeljeschl Ger [Allemagne] ; Eckart Rüther [Allemagne]Severe tardive dystonia: Treatment with continuous intrathecal baclofen administration
005270 (1997) Derex [France] ; P. Trouillas [France]Reversible parkinsonism, hypophosphoremia, and hypocalcemia under vitamin D therapy
005397 (1997) Truong [États-Unis] ; Paul A. Cullis [États-Unis] ; Christopher F. O'Brien [États-Unis] ; Martin Koller [États-Unis] ; Timothy P. Villegas [États-Unis] ; Jan D. Wallace [États-Unis]BotB (botulinum Toxin type B): Evaluation of safety and tolerability in botulinum toxin type A‐Resistant cervical dystonia patients (preliminary study)
005399 (1997) Schuurman [Pays-Bas] ; Rob M. A. De Bie [Pays-Bas] ; Johannes D. Speelman [Pays-Bas] ; D. Andries Bosch [Pays-Bas]Bilateral posteroventral pallidotomy in advanced parkinson's disease in three patients
005B92 (1994) Greene [États-Unis] ; Stanley Fahn [États-Unis] ; Beverly Diamond [États-Unis]Development of resistance to botulinum toxin type A in patients with torticollis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Drug Resistance" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Drug Resistance" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Drug Resistance
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024